Literature DB >> 16139020

Indocyanine green angiography of juvenile X-linked retinoschisis.

Eric H Souied1, Anna Goritsa, Giuseppe Querques, Gabriel Coscas, Gisele Soubrane.   

Abstract

PURPOSE: In juvenile X-linked retinoschisis (XLRS), fluorescein angiography is usually unremarkable and contributes poorly to the diagnosis. However, indocyanine green (ICG) angiography features in eyes that are affected with XLRS were not yet described.
DESIGN: Retrospective observational case series.
METHODS: A complete ophthalmologic examination that included ICG angiography was performed on three unrelated male patients (six eyes) who were 15, 22, and 48 years old.
RESULTS: A distinct hyperfluorescent stellate pattern in the macular area that was associated with radial lines of hypofluorescence that were centered on the foveola was observed on the early phase of ICG examination (six of six eyes). This feature disappeared on the late phase of ICG examination.
CONCLUSION: On these six XLRS eyes, early phases of ICG examination revealed an unusual radial aspect on the macula. This finding suggests that ICG angiography may be useful for the diagnosis of XLRS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16139020     DOI: 10.1016/j.ajo.2005.03.051

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  Swept-source and optical coherence tomography angiography in patients with X-linked retinoschisis.

Authors:  N Padrón-Pérez; J Català-Mora; J Díaz; L Arias; J Prat; J M Caminal
Journal:  Eye (Lond)       Date:  2018-01-05       Impact factor: 3.775

Review 2.  X-linked retinoschisis: an update.

Authors:  Stephen K Sikkink; Susmito Biswas; Neil R A Parry; Paulo E Stanga; Dorothy Trump
Journal:  J Med Genet       Date:  2006-12-15       Impact factor: 6.318

3.  X-Linked Retinoschisis in Females in a Consanguineous Family: A Rare Entity

Authors:  Mehmet Önen; Kürşat Zor; Erkut Küçük; Gamze Yıldırım
Journal:  Turk J Ophthalmol       Date:  2020-08-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.